It is essential to increase the level of awareness for the need to preserve the integrity of the venous system in the dialysis patient. Central venous stenosis is a major problem for this population, effectively excluding an affected individual from the safest and most efficacious form of vascular access—a native upper limb fistula. Amongst end-stage renal failure (ESRF) patients central venous stenosis is most common in those who have had subclavian catheterization with an observed incidence of over 40% [1]. Current treatment of central stenosis is by angioplasty and stenting [for early (<3 months) recurrence and elastic lesions]. However, there is an initial failure rate of 30% and recurrence within a year is the norm [2]. Managing the access of such patients is often made more complex by the presence of significant peripheral vascular disease in the lower limbs. This precludes a lower limb fistula based on the femoral vessels because of the significant risk of a ‘steal syndrome’ or frank gangrene.
No takes yet. Share an insight, caveat, or question.
Calder et al. (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: